University of Alabama at Birmingham
OrganisationROR
People
Professorreporter.nih.gov
Joy and Bill Harbert Endowed Chair28 Sept 2026uab.edu
Professor15 Aug 2026reporter.nih.gov
15 Aug 2026reporter.nih.gov
Professor26 Jun 2026reporter.nih.gov
Professor of medicine26 Jun 2026reporter.nih.gov
Assistant professor18 Jun 2026reporter.nih.gov
Professor18 Jun 2026reporter.nih.gov
Professor18 Jun 2026reporter.nih.gov
Assistant professor16 Jun 2026reporter.nih.gov
Associate professor16 Jun 2026reporter.nih.gov
Professor3 Jun 2026reporter.nih.gov
Associate professor3 Jun 2026reporter.nih.gov
Professor26 May 2026reporter.nih.gov
Professor26 May 2026reporter.nih.gov
Professor of medicine26 May 2026reporter.nih.gov
Assistant professor22 May 2026reporter.nih.gov
Trials
No phaseNot yet recruiting202730 people31 Jul 2026clinicaltrials.gov
Phase 2Not yet recruiting202755 people13 Apr 2026clinicaltrials.gov
No phaseRecruiting20265,000 people24 Jun 2025clinicaltrials.gov
CollaboratorPhase 2Not yet recruiting202629 people3 Mar 2025clinicaltrials.gov
Phase 4Recruiting2025100 people17 Feb 2025clinicaltrials.gov
Remote vs. In-Person Study Evaluation (RISE) Trials: RISE Above Smoking (Trial 1)
CollaboratorPhase 2/3Completed2025200 people12 Feb 2025clinicaltrials.gov
Remotely Delivered Mindfulness-Based Diabetes Education
No phaseNot yet recruiting202680 people15 Mar 2024clinicaltrials.gov
Phase 2Withdrawn20250 people1 Jun 2023clinicaltrials.gov
Phase 1/2Active, not recruiting2023126 people14 Nov 2022clinicaltrials.gov
Phase 2Withdrawn20250 people4 Aug 2022clinicaltrials.gov
Phase 1/2Active, not recruiting202380 people28 Jun 2022clinicaltrials.gov
No phaseCompleted2022416 people10 May 2022clinicaltrials.gov
Phase 4Terminated202238 people7 Apr 2022clinicaltrials.gov
Phase 2Active, not recruiting2023300 people9 Feb 2022clinicaltrials.gov
GENESIS: Genotype Guided - Natriuretic Peptides - Cardiometabolic Health Study
No phaseRecruiting2022200 people31 Jan 2022clinicaltrials.gov
Phase 3Active, not recruiting2022100 people28 Oct 2021clinicaltrials.gov
Phase 2Recruiting202140 people5 Aug 2021clinicaltrials.gov
Phase 2Withdrawn20270 people22 Oct 2020clinicaltrials.gov
CollaboratorPhase 2Active, not recruiting20201,500 people27 Jul 2020clinicaltrials.gov
Phase 3Completed202032 people24 Apr 2020clinicaltrials.gov
Grants and prizes
N01CORONARY ARTERY RISK DEVELOPMENT IN YOUNG ADULTS (CARDIA) STUDY - COORDINATING CENTER (CC)75N92023D00US$1.3m2026–2027reporter.nih.gov
N01CORONARY ARTERY RISK DEVELOPMENT IN YOUNG ADULTS (CARDIA) STUDY - BIRMINGHAM FIELD CENTER75N92023D00US$771.8k2026–2037reporter.nih.gov
N01CORONARY ARTERY RISK DEVELOPMENT IN YOUNG ADULTS (CARDIA) STUDY - COORDINATING CENTER (CC)75N92023D00US$1.8m2023–2027reporter.nih.gov
N01CORONARY ARTERY RISK DEVELOPMENT IN YOUNG ADULTS (CARDIA) STUDY - BIRMINGHAM FIELD CENTER75N92023D00US$751.1k2023–2027reporter.nih.gov
National Center for Chronic Disease Prev and Health Promo
U01RFA-DP-24-081 Implementing AI-based Glaucoma Screening within Federally Qualified Health CentersU01DP006827US$750k2024–202715 Aug 2026reporter.nih.gov
National Heart, Lung, and Blood Institute
R01Improving Chronic Limb Threatening Ischemia Across the USR01HL178865US$735.3k2026–203026 Jun 2026reporter.nih.gov
National Heart, Lung, and Blood Institute
K23Adapting and Piloting a Stress Management Intervention to Reduce Cardiovascular Disease Risk among Women Living with HIVK23HL170836US$149k2024–202818 Jun 2026reporter.nih.gov
National Institute of Diabetes and Digestive and Kidney Diseases
R01Timing of Diet and Kidney Pathophysiology in Diet-Induced ObesityR01DK134562US$639.4k2023–202818 Jun 2026reporter.nih.gov
National Heart, Lung, and Blood Institute
R01Molecular Regulation of Functional Maturation in Human Direct Cardiac ReprogrammingR01HL153220US$487.4k2020–203116 Jun 2026reporter.nih.gov
R21Ketogenic Approach to Restore Muscle in older patients with community-Acquired Pneumonia - KARMA-P TrialR21AG098466US$409.8k2026–202816 Jun 2026reporter.nih.gov
National Heart, Lung, and Blood Institute
R01Clinical Implementation of Blood Pressure Polygenic Risk Score: A Randomized Clinical TrialR01HL176882US$726.8k2025–20303 Jun 2026reporter.nih.gov
National Heart, Lung, and Blood Institute
R01Sleep and Circadian Contributions to Nighttime Blood Pressure Rhythms (SCN-BP)R01HL167230US$536.8k2023–20283 Jun 2026reporter.nih.gov
National Heart, Lung, and Blood Institute
R01The Effects of Neprilysin Inhibition on Cardiometabolic Health in Black IndividualsR01HL163852US$723.8k2022–20273 Jun 2026reporter.nih.gov
R21Comprehensive Determination of Isoprostanoid MetabolismR21AG081823US$175k2024–202726 May 2026reporter.nih.gov
U54Center for Cancer Control in Persistent Poverty Areas (C3P2)U54CA280770US$1.9m2023–202826 May 2026reporter.nih.gov
R56Novel Retinal Biomarker Development in Early Alzheimer's DiseaseR56AG096140US$406k2026–202722 May 2026reporter.nih.gov
National Institute of General Medical Sciences
R35Understanding pathology of sepsis-induced physical disability for future precision medicineR35GM151038US$344.7k2023–202818 May 2026reporter.nih.gov
P30UAB Alzheimer's Disease Research CenterP30AG086401US$4.3m2024–202914 May 2026reporter.nih.gov
National Heart, Lung, and Blood Institute
K08Clonal Hematopoiesis in a Biracial PopulationK08HL159290US$164k2022–202714 May 2026reporter.nih.gov
National Institute on Drug Abuse
R01Assessment of metformin for restoration of immune homeostasis in HIV+ and HIV- individuals with a history of injection drug useR01DA060692US$1.1m2024–202912 May 2026reporter.nih.gov